News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Pierre Blanchard: The molecular analysis of the PEACE 1 trial
Collage photo of Pierre Blanchard and Cedric Pobel
Sep 18, 2024, 16:38

Pierre Blanchard: The molecular analysis of the PEACE 1 trial

Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X:

“Dr Pobel at ESMO2024 presenting the molecular analysis of the PEACE 1 trial. Identifies molecular phenotypes and prognostic markers but no interaction with abiraterone efficacy Major undertaking by GETUG, Gustave Roussy.”

Pierre Blanchard

Source: Pierre Blanchard/X

More posts featuring ESMO24 on oncodaily.com

 

cancer Cédric Pobel ESMO24 GETUG Gustave Roussy OncoDaily Oncology Pierre Blanchard
Special Coverage
Celebrities
Jan 16, 2025, 17:18
Bob Uecker Dies at 90 from Small-Cell Lung Cancer
Insight
Jan 16, 2025, 16:45
The 2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
Insight
Jan 16, 2025, 16:28
ACS CAN Report: High Costs Block Critical Follow-Up Tests for Breast Cancer
Blog
Jan 16, 2025, 16:20
Genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC - ASGO Education
Science
Jan 16, 2025, 16:10
Neoadjuvant therapy in patients with left-sided resectable pancreatic cancer
Blog
Jan 16, 2025, 16:05
David Wakeling: Alice’s Arc’s new research grant to some of the best minds in US paediatric cancer research
Science
Jan 16, 2025, 16:03
Estela Rodriguez: Updated analysis of CM816
Blog
Jan 16, 2025, 16:01
Elizabeth Ugwoma Awo-Ejeh: The Power of Showing Up - Closing the 10-Day Challenge
Career
Jan 16, 2025, 15:57
Elene Mariamidze: I finally got into the 2025 IASLC Academy
Insight
Jan 16, 2025, 15:50
The Gynaecology Course at the 17th BGICC
Insight
Jan 16, 2025, 15:49
Elvina Almuradova: Delighted to continue serving as a ESO Ambassador for Turkey
Blog
Jan 16, 2025, 15:46
Roupen Odabashian: Why do I see more young patients with cancer?